Author Archives: RJ Health

The following questions were submitted by attendees during the most recent Quarterly Drug Coding, Reimbursement, and Pipeline Update Webinar for Q3 2019. or      Q:  On the “Pricing Updates” slide it shows that the majority of Code Price changes were increases, but the Medicare Allowable ASP price changes showed a majority which were decreases. Why […]

Join RJ’s Jason Young – SVP Clinical Data Operations, Todd Cooperman – SVP Clinical Insights and Analytics, and Chris Webb – Director of Product Development, as they review the drug coding updates, revisions, and issues observed over 2019’s third quarter. October 8th, 2pm EST Learn about: New and Existing Code Updates – HCPCS Codes: J […]

Wondering about the different types of HCPCS (Healthcare Common Procedure Coding System) codes and how they apply to reimbursement? Chris and Jason walk through HCPCS and CPT® (Current Procedural Terminology) code background in this edition of Drug Pricing and Reimbursement 101. These webinar clips from “Shedding Light on Medically Covered Specialty Drug Pricing Methods” touch […]

Join RJ’s Product and Clinical teams as they walk through the multitude of different combinations of drug claims and pricing methodologies, via clips from the webinar “Shedding Light on Medically Covered Specialty Drug Pricing Methods.” In the following clip, Chris Webb explains the application and breakdown of the NDC or National Drug Code. All past […]

Have questions about how drugs are priced? Wondering which pricing methodologies apply to your drug claim? Curious about the origins of the various types of drug codes? Join RJ’s Product and Clinical teams as they walk through the multitude of different combinations of drug claims and pricing methodologies, via clips from the webinar “Shedding Light […]

Beginning April 29 and continuing to May 2, Asembia will be hosting its 15th annual Specialty Pharmacy Summit at Wynn & Encore in Las Vegas. RJ Health is excited to join the many pharmacies, health systems, pharmaceutical manufacturers, PBMs, health plans, technology companies, and consulting firms that will be in attendance. The agenda includes continued […]

Increasing healthcare costs continue to outpace inflation in the United States. Specialty drug costs are the largest driver and component to healthcare spend. This surge has led to transformative patent care but has also given rise to a disproportionate total healthcare spend. Major drivers of medical drug spend are the complex processing of medical drug […]

Biosimilars are intricate in their makeup and the process for FDA approval is even more multidimensional.  Todd Cooperman’s (PharmD, MBA, R.Ph.) recent whitepaper provides insight into biosimilars in the U.S. healthcare marketplace.  Below is a caption from the introduction of the whitepaper. Initial Food and Drug Administration (FDA) guidance on the biosimilar pathway was intentionally vague, […]

RJ Health will be exhibiting at several healthcare trade shows Spring 2017. We will be attending the following tradeshows: 14th Annual World Health Care Congress Convenes decision makers from all sectors of health care to catalyze meaningful partnerships and change. In 2017, faculty focus on policy and market forces impacting the health care business environment including […]

RJ Health Systems is hitting the road this spring! Our team will be attending and exhibiting at several conferences to share our solutions with Payors, PBMs, Specialty Pharmacies, Infusion Companies, Medicaid Organizations, Physicians and Medical Billing companies. Visit our booth to learn how we can help you save time and money managing specialty drug trend. […]